International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation.

Divisione di Ematologia dell'Università di Torino, Azienda Ospedaliera S. Giovanni Battista, Ospedale Molinette, Torino 10126, Italy.
Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, U.K (Impact Factor: 9.38). 07/2009; 23(10):1716-30. DOI: 10.1038/leu.2009.122
Source: PubMed

ABSTRACT In 2005, the first guidelines were published on the management of patients with multiple myeloma (MM). An expert panel reviewed the currently available literature as the basis for a set of revised and updated consensus guidelines for the diagnosis and management of patients with MM who are not eligible for autologous stem cell transplantation. Here we present recommendations on the diagnosis, treatment of newly diagnosed non-transplant-eligible patients and the management of complications occurring during induction therapy among these patients. These guidelines will aid the physician in daily clinical practice and will ensure optimal care for patients with MM.

Download full-text


Available from: Jae Hoon Lee, Jul 02, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objectives. The aim of this study was to assess the psychometric properties of the Greek EORTC QLQ-C30 and QLQ-MY20 instruments. Method. A sample of myeloma patients (N = 89) from two tertiary hospitals were surveyed with the QLQ-C30, QLQ-MY20 and various demographic and disease related questions. The previously validated Greek SF-36 instrument was used as a "gold standard" for health-related quality of life (HRQoL) comparisons. Hypothesized scale structure, internal consistency reliability (Cronbach's alpha) and various forms of construct validity (convergent, discriminative, concurrent and known-groups) were assessed. Results. Multitrait scaling confirmed scale structure of the QLQ-C30 and QLQ-MY20, with good item convergence (96% and 72%) and discrimination (78% and 58%) rates. Cronbach's α was >0.70 for all but one scale (cognitive functioning). Spearman's correlations between similar QLQ-C30 and SF-36 scales ranged between 0.35-0.80 (P < 0.001). Expected interscale correlations and known-groups comparisons supported construct validity. QLQ-MY20 scales showed comparatively lower correlations with QLQ-C30 functional scales, and higher correlations with conceptually related symptom scales. Conclusions. The observed psychometric properties of the two instruments imply suitability for assessing myeloma HRQoL in Greece. Future studies should focus on generalizability of the results, as well as on specific issues such as longitudinal validity and responsiveness.
    The Scientific World Journal 08/2012; 2012(1):842867. DOI:10.1100/2012/842867 · 1.73 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A turbo coded hybrid automatic repeat request (TC-HARQ) scheme is proposed based on packet combining technique and segment selective repeat. First, we demonstrate through simulation that, data combining gives substantial performance improvement over log-likelihood ratio (LLR) combining with the cost of more buffers. Second, we propose a novel retransmission strategy for TC-HARQ: segment selective repeat (SSR), which intends to select the worst corrupted part of the packet for retransmission. We show that SSR increases system throughput and has a potential to perform better with more sophisticated use of LLR.
    Wireless Communications and Networking Conference, 2004. WCNC. 2004 IEEE; 04/2004